Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|30|3219-3230

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.30, 2008-10, pp. : 3219-3230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 587-596

Bentham Science Publishers

Access to resources Recommend Favorite

Celiac Disease: Pathogenesis and Novel Therapeutic Strategies

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 3, 2008-09 ,pp. : 152-158

Bentham Science Publishers

Access to resources Recommend Favorite

Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

By  

Current Medicinal Chemistry, Vol. 13, Iss. 16, 2006-07 ,pp. : 1903-1913

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Therapeutic Approaches to Transthyretin Amyloidosis

By  

Current Medicinal Chemistry, Vol. 19, Iss. 15, 2012-04 ,pp. : 2312-2323

Bentham Science Publishers

Access to resources Recommend Favorite

EDITORIAL [Hot Topic: Transthyretin: A Small Protein in the Big World of Amyloidoses (Guest Editors: Adriano Martinelli and Gabriella Ortore)]

By  

Current Medicinal Chemistry, Vol. 19, Iss. 15, 2012-04 ,pp. : 2303-2303

Bentham Science Publishers

Access to resources Recommend Favorite